Bulletin
Investor Alert

ADC Therapeutics S.A.

NYS: ADCT

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Mar 28, 2023, 7:03 p.m.

/zigman2/quotes/214411413/composite

$

1.94

Change

0.00 0.00%

Volume

Volume 1,654

Quotes are delayed by 20 min

/zigman2/quotes/214411413/composite

Today's close

$ 1.98

$ 1.94

Change

-0.04 -2.02%

Day low

Day high

$1.92

$2.06

Open

52 week low

52 week high

$1.85

$16.04

Open
Sorry, there are no insider transactions for this symbol.

Transaction Summary

Total insider purchases and sales reported to the SEC

Data not available.

Officers and Executives

Mr. Ron Squarer
Chairman
Mr. Ameet Mallik
President, Chief Executive Officer & Director
Mr. Jose Carmona
Chief Financial Officer
Dr. Michael Mulkerrin
Chief Technical Operations Officer
Dr. Mohamed Zaki
Chief Medical Officer
Dr. Patrick van Berkel
Chief Scientific Officer
Ms. Susan Romanus
Chief Compliance & Quality Officer
Mr. David Gilman
Chief Business & Strategy Officer
Ms. Kristen Harrington-Smith
Chief Commercial Officer
Dr. Jean-Pierre Bizzari
Non-Executive Director
Mr. Michael Forer
Vice Chairman
Dr. Christopher John Martin
Non-Executive Director
Ms. Amanda Hamilton
Head-Investor Relations
Ms. Kimberly Pope
Chief People Officer
Mr. Peter J. Graham
Chief Legal Officer
Dr. Tyrell J. Rivers
Independent Non-Executive Director
Dr. Victor Sandor
Independent Non-Executive Director
Ms. Viviane Monges
Independent Non-Executive Director
Mr. Stephen Ralfe Evans-Freke
Independent Non-Executive Director
Mr. Jacques Theurillat
Independent Non-Executive Director
Mr. Thomas Pfisterer
Independent Non-Executive Director
Dr. Peter Hug
Independent Non-Executive Director
Link to MarketWatch's Slice.